COLORADO SPRINGS, Colo., May 9 /PRNewswire-FirstCall/ -- The Spectranetics Corporation today announced that it has closed its public offering of 4,140,000 shares of common stock, which amount includes the exercise in full by the underwriters of its over-allotment option of 540,000 shares. Spectranetics intends to use the estimated net proceeds from the offering of approximately $47.9 million for capital expenditures, working capital and other general corporate purposes and business development activities.
Jefferies & Company, Inc. acted as the sole book runner and lead managing underwriter. First Albany Capital Inc. acted as the co-lead manager, and Montgomery & Co., LLC and Rodman & Renshaw, LLC acted as co-managers for the offering.
About Spectranetics
Spectranetics develops, manufactures and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system for use with its proprietary excimer laser system.
Spectranetics is the registered trademark of The Spectranetics Corporation.
COMPANY CONTACT: Spectranetics Corporation John Schulte, Chief Executive Officer Guy Childs, Chief Financial Officer (719) 633-8333 INVESTOR & MEDIA CONTACTS: Lippert/Heilshorn & Associates, Inc. Don Markley or Bruce Voss (310) 691-7100 dmarkley@lhai.com
Spectranetics Corporation
CONTACT: John Schulte, Chief Executive Officer, or Guy Childs, ChiefFinancial Officer, both of Spectranetics Corporation, +1-719-633-8333; orInvestors & Media, Don Markley, dmarkley@lhai.com, or Bruce Voss, both ofLippert/Heilshorn & Associates, Inc., +1-310-691-7100, for SpectraneticsCorporation
Web site: http://www.spectranetics.com//
